ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding ADC Therapeutics SA changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 59 | 56 | −3 |
| Shares | 32.8M | 33.5M | +706.9K (+2.2%) |
| Value | $801.3M | $816.3M | +$15.0M (+1.9%) |
New holders (8)
Institutions that held ADC Therapeutics SA at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 300,738 | $7.32M | 0.00% |
| Alps Advisors Inc | 100,356 | $2.44M | 0.02% |
| Susquehanna Fundamental Investments, LLC | 43,017 | $1.05M | 0.02% |
| Cubist Systematic Strategies, LLC | 16,252 | $396.0K | 0.00% |
| FORA Capital, LLC | 1,089 | $27.0K | 0.01% |
| Sandy Spring Bank | 1,000 | $24.0K | 0.00% |
| Salem Investment Counselors Inc | 35 | $1.00K | 0.00% |
| Point72 Hong Kong Ltd | 2 | $0 | 0.00% |
Sold out (11)
Institutions that held ADC Therapeutics SA at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Matthews International Capital Management LLC | 607,800 | $14.8M |
| Frontier Capital Management Co LLC | 78,137 | $1.91M |
| California Public Employees Retirement System | 73,925 | $1.80M |
| Henry James International Management, Inc. | 15,009 | $366.0K |
| SG Americas Securities, LLC | 5,000 | $122.0K |
| Simplex Trading, LLC | 936 | $22.0K |
| Valeo Financial Advisors, LLC | 150 | $4.00K |
| Steward Partners Investment Advisory, LLC | 125 | $3.05K |
| Tower Research Capital LLC (TRC) | 82 | $2.00K |
| Bank of Montreal | 35 | $1.00K |
| Candriam Luxembourg S.C.A. | 8 | $0 |